Home > Financial Ratios > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 13.551.571.551.401.55

What is the latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of EMCURE PHARMACEUTICALS is 13.55 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202513.55
Mar20241.57
Mar20231.55
Mar20221.40
Mar20211.55

How is EV/Core EBITDA of EMCURE PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2025 13.55
763.06
Mar2024 1.57
1.29
Mar2023 1.55
10.71
Mar2022 1.4
-9.68
Mar2021 1.55 -

Other Financial Ratios of EMCURE PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹29,664.8 Cr 6.6% 3.2% 61.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹434,999.0 Cr 3.6% 7% 15.3% Stock Analytics
DIVIS LABORATORIES ₹169,139.0 Cr 1.1% 5.8% 14.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,791.0 Cr 1.9% 12.3% 49.2% Stock Analytics
DR REDDYS LABORATORIES ₹109,664.0 Cr 1.8% 5.9% 14.8% Stock Analytics
CIPLA ₹107,685.0 Cr 1.6% 0.2% -5.4% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

6.6%

3.2%

61.3%

SENSEX

-2.5%

-6.1%

7%


You may also like the below Video Courses